Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke

نویسندگان

چکیده

Circulating neutrophil extracellular traps (NETs) resistant to t-PA have not been studied completely although NETs in thrombi may contribute tissue plasminogen activator (t-PA) resistance. This research intended elucidate whether circulating are associated with resistance and the underlying mechanism. The levels of were detected neutrophils, ischemic brain acute stroke (AIS) patients, transient middle cerebral artery occlusion (tMCAO) models. NET formation blood, thrombi, mice analyzed by immunofluorescence. Exposed phosphatidylserine (PS) was assessed using flow cytometry confocal microscopy. Procoagulant activity (PCA) evaluated fibrin assays, thrombin, purified coagulation complex. plasma AIS patients significantly higher than those healthy individuals. After thrombolysis, a significant increase noted markers no-improvement while changes improvement significant. Importantly, decorated von Willebrand factor (vWF) inhibitor-1 (PAI-1) blood which could reverse fibrinolytic effects. In addition, activated platelets (PLTs) endothelial cells (ECs), stimulating procoagulant phenotype facilitating vWF PAI-1 release. DNase I, protein C (APC), sivelestat markedly inhibited these Furthermore, targeting protected from tMCAO-induced ischemia, possibly regulating PAI-1. summary, through activation PLTs ECs. Strategies against present promising therapeutic approach improve thrombolysis efficiency patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...

متن کامل

pharmacotherapy updates of recombinant tissue plasminogen activator (r-tpa) in acute ischemic stroke

conclusions due to considerable inter- and intra- heterogeneity among studies performed by other centers such as differences in study project, background, and population features, determining a pharmacotherapy model based on safe implementation of treatments in stroke or sits seem advantageous. results age, time of onset, systolic blood pressure, diabetes, stroke severity, co-morbidities and pr...

متن کامل

Tissue-type plasminogen activator for acute ischemic stroke.

BACKGROUND AND PURPOSE Several studies are currently evaluating tissue-type plasminogen activator (TPA) as a potential therapy in acute ischemic stroke. The possibility of inducing intracranial hematomas, however, introduces an important concern into ultimate evaluation of risk and benefit. This retrospective analysis sought to identify factors associated with intracranial hematoma formation in...

متن کامل

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke.

Dates to which data relate Effectiveness and resource use data were extracted from NINDS rt-PA Stroke Trial conducted between January 1991 and October 1994, the results of which were published in 1995. Clinical probabilities relating to the epidemiological course of events were obtained from studies published between 1982 and 1997. The utility values related to different discharge states were b...

متن کامل

Low-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.

BACKGROUND The burden of stroke is becoming an important issue in Asian countries, where half of the world's population lives. In Western populations, standard-dose intravenous tissue plasminogen activator (tPA) at a dose of 0.9 mg/kg administered up to 4.5 h following acute ischaemic stroke has been shown to improve clinical outcomes. However, the dosage of tPA in Asian populations varies, par...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: The FASEB Journal

سال: 2021

ISSN: ['0892-6638', '1530-6860']

DOI: https://doi.org/10.1096/fj.202100471rr